hATTR amyloidosis

Alnylam wins FDA approval of rare disease drug in step toward profitability
BioPharma Dive
Tue, 06/14/22 - 11:14 am
Alnylam
FDA
Amvuttra
hATTR amyloidosis
AAN 2021 – Helios backs Alnylam’s sunny forecasts
EP Vantage
Wed, 04/21/21 - 10:28 am
Alnylam
AAN
vutrisiran
Onpattro
hATTR amyloidosis
Alnylam Pharmaceuticals and Gen sign distribution agreement in Turkey for ONPATTRO (patisiran)
Pharmaceutical Business Review
Thu, 03/26/20 - 10:22 am
Alnylam
RNAi
Gen
Onpattro
Turkey
hATTR amyloidosis
Alnylam's Onpattro sales look 'disappointing' in early days of RNAi launch: analyst
Fierce Pharma
Mon, 11/19/18 - 11:31 am
Alnylam
RNAi
Onpattro
hATTR amyloidosis
FDA clears rare disease therapy from Akcea, Ionis
Biopharma Dive
Fri, 10/5/18 - 09:38 pm
FDA
Akcea
Ionis Pharmaceuticals
Tegsedi
Onpattro
Alnylam
hATTR amyloidosis
Alnylam Submits NDA in Japan for Onpattro for Hereditary ATTR Amyloidosis
CP Wire
Fri, 09/28/18 - 10:34 am
Alnylam
Patisiran
Onpattro
Japan
hATTR amyloidosis
Alnylam Announces Encouraging Exploratory Cardiac Endpoint Data For Patisiran in hATTR Amyloidosis
CP Wire
Fri, 09/14/18 - 09:40 am
Alnylam
Patisiran
hATTR amyloidosis
Onpattro
Alnylam Announces Encouraging Exploratory Cardiac Endpoint Data For Patisiran in hATTR Amyloidosis
Fri, 09/14/18 - 09:35 am
Alnylam
hATTR amyloidosis
Patisiran
3 Things Alnylam's Management Wants Investors to Know About the Launch of Onpattro
Motley Fool
Mon, 08/20/18 - 10:05 am
Alnylam
Onpattro
hATTR amyloidosis
drug pricing
labeling
2 Reasons Alnylam Stock Fell on a Landmark Drug Approval
Motley Fool
Fri, 08/17/18 - 09:25 pm
Alnylam
FDA
Onpattro
hATTR amyloidosis
Alnylam Prices First Gene Silencing Drug At $450,000 Per Patient, But Offers Money-Back Guarantee
Forbes
Sun, 08/12/18 - 01:19 pm
Alnylam
FDA
drug pricing
hATTR amyloidosis
Onpattro
In first, FDA approves RNA interference drug from Alnylam
Biopharma Dive
Fri, 08/10/18 - 02:25 pm
Alnylam
RNAi
FDA
Patisiran
Onpattro
hATTR amyloidosis
Xconomy: Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
Xconomy
Fri, 08/3/18 - 11:45 am
FDA
Alynylam
Patisiran
hATTR amyloidosis
The UK's MHRA Grants Early Access to Anlylam's Patisiran
CP Wire
Fri, 08/3/18 - 09:23 am
Alnylam
Patisiran
hATTR amyloidosis
UK
The UK's MHRA Grants Early Access to Anlylam's Patisiran
Fri, 08/3/18 - 09:01 am
Alnylam
Patisiran
hATTR amyloidosis
Alnylam Receives Positive CHMP Opinion for Hereditary Amyloidosis Treatment
CP Wire
Fri, 07/27/18 - 10:22 am
Alnylam
Patisiran
EMA
hATTR amyloidosis
Alnylam Receives Positive CHMP Opinion for Hereditary Amyloidosis Treatment
Fri, 07/27/18 - 10:01 am
Alnylam
Patisiran
hATTR amyloidosis